Deutsche Bank’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,999
| Closed | -$99K | – | 3618 |
|
|
2025
Q2 | $99K | Buy |
5,999
+1,126
| +23% | +$19.4K | ﹤0.01% | 3262 |
|
|
2025
Q1 | $88.7K | Buy |
4,873
+2,696
| +124% | +$77K | ﹤0.01% | 3234 |
|
|
2024
Q4 | $80.8K | Hold |
2,177
| – | – | ﹤0.01% | 3340 |
|
|
2024
Q3 | $69.7K | Buy |
2,177
+856
| +65% | +$47.5K | ﹤0.01% | 3296 |
|
|
2024
Q2 | $108K | Sell |
1,321
-1,504
| -53% | -$163K | ﹤0.01% | 3083 |
|
|
2024
Q1 | $409K | Buy |
2,825
+454
| +19% | +$38.3K | ﹤0.01% | 2450 |
|
|
2023
Q4 | $218K | Sell |
2,371
-2,028
| -46% | -$206K | ﹤0.01% | 2830 |
|
|
2023
Q3 | $726K | Buy |
4,399
+209
| +5% | +$27.2K | ﹤0.01% | 1924 |
|
|
2023
Q2 | $265K | Sell |
4,190
-3,776
| -47% | -$229K | ﹤0.01% | 2725 |
|
|
2023
Q1 | $270K | Sell |
7,966
-411
| -5% | -$21.5K | ﹤0.01% | 2850 |
|
|
2022
Q4 | $484K | Buy |
8,377
+3,626
| +76% | +$224K | ﹤0.01% | 2459 |
|
|
2022
Q3 | $447K | Sell |
4,751
-2,925
| -38% | -$416K | ﹤0.01% | 2435 |
|
|
2022
Q2 | $1.71M | Sell |
7,676
-820
| -10% | -$275K | ﹤0.01% | 1852 |
|
|
2022
Q1 | $4.67M | Sell |
8,496
-345
| -4% | -$208K | ﹤0.01% | 1456 |
|
|
2021
Q4 | $5.84M | Buy |
8,841
+1,094
| +14% | +$836K | ﹤0.01% | 1352 |
|
|
2021
Q3 | $6.5M | Buy |
7,747
+1,003
| +15% | +$1.02M | ﹤0.01% | 1369 |
|
|
2021
Q2 | $8.56M | Sell |
6,744
-8,836
| -57% | -$9.97M | ﹤0.01% | 1253 |
|
|
2021
Q1 | $17.1M | Buy |
15,580
+5,966
| +62% | +$7.88M | 0.01% | 955 |
|
|
2020
Q4 | $13.7M | Buy |
9,614
+5,807
| +153% | +$6.19M | 0.01% | 922 |
|
|
2020
Q3 | $2.69M | Buy |
3,807
+182
| +5% | +$132K | ﹤0.01% | 1561 |
|
|
2020
Q2 | $2.54M | Buy |
3,625
+2,621
| +261% | +$1.51M | ﹤0.01% | 1659 |
|
|
2020
Q1 | $351K | Sell |
1,004
-27,163
| -96% | -$19.2M | ﹤0.01% | 2661 |
|
|
2019
Q4 | $17.7M | Buy |
28,167
+23,405
| +491% | +$11.4M | 0.01% | 832 |
|
|
2019
Q3 | $1.59M | Buy |
4,762
+3,669
| +336% | +$1.18M | ﹤0.01% | 2040 |
|
|
2019
Q2 | $282K | Buy |
1,093
+343
| +46% | +$68.7K | ﹤0.01% | 3635 |
|
|
2019
Q1 | $122K | Sell |
750
-28
| -4% | -$4.55K | ﹤0.01% | 4227 |
|
|
2018
Q4 | $83K | Sell |
778
-567
| -42% | -$95.6K | ﹤0.01% | 4289 |
|
|
2018
Q3 | $336K | Buy |
1,345
+261
| +24% | +$56.2K | ﹤0.01% | 3988 |
|
|
2018
Q2 | $236K | Buy |
1,084
+394
| +57% | +$72.9K | ﹤0.01% | 4210 |
|
|
2018
Q1 | $100K | Buy |
+690
| New | +$117K | ﹤0.01% | 4496 |
|
Other funds holding CDLX
CIP
KGAMU
6CM
WPM
QOP
RC
Deutsche Bank's CDLX Position: Q3 2025 in Review
Deutsche Bank sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 5,999 shares — an estimated $99K sold.
Deutsche Bank first reported a position in CDLX in Q1 2018 and held it in 30 quarters. The position peaked at $17.7M in Q4 2019. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.
- Deutsche Bank reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
- Deutsche Bank sold 5,999 Cardlytics shares in Q3 2025, an estimated $99K.
- Deutsche Bank first reported a position in Cardlytics in Q1 2018 and held it in 30 quarters.
- Deutsche Bank's Cardlytics position peaked at $17.7M in Q4 2019.
- 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.
Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.